Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.


home / news releases / HRTX - Heron Therapeutics Inc. (HRTX) CEO Barry Quart on Q1 2022 Results - Earnings Call Transcript

HRTX - Heron Therapeutics Inc. (HRTX) CEO Barry Quart on Q1 2022 Results - Earnings Call Transcript

Heron Therapeutics Inc.
Heron Therapeutics, Inc. (HRTX) Q1 2022 Results Conference Call May 09, 2022 04:30 PM ET Company Participants David Szekeres - EVP and COO Barry Quart - Chairman and CEO John Poyhonen - President and Chief Commercial Officer Kimberly Manhard - EVP, Drug Development and Board Director Conference Call Participants Brandon Folkes - Cantor Fitzgerald Josh Schimmer - Evercore ISI Serge Belanger - Needham and Company Boris Peaker - Cowen Kelly Shi - Jefferies Presentation Operator Good day, ladies and gentlemen, and thank you for standing by. Welcome to the Heron Therapeutics First Quarter 2022 Earnings Conference. As a reminder, this conference is being recorded. Now, I would like to turn the call over to David Szekeres, Executive Vice President, Chief Operating Officer. Please proceed. David Szekeres Thank you, Jason. Good afternoon, everyone, and thank you for joining us. With me today from Heron are Barry Quart, Chief Executive Officer and

For further details see:

Heron Therapeutics, Inc. (HRTX) CEO Barry Quart on Q1 2022 Results - Earnings Call Transcript
Stock Information
Company Name: Heron Therapeutics Inc.
Stock Symbol: HRTX
Market: NASDAQ
Website: herontx.com
Menu
HRTX HRTX Quote HRTX Short HRTX News HRTX Articles HRTX Message Board
Get HRTX Alerts

News, Short Squeeze, Breakout and More Instantly...